IGM Biosciences, Inc. (IGMS) [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Sep-30-22	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21	Jun-30-21
	10-Q	10-Q	10-Q	10-Q	10-Q	10-K	10-Q	10-Q
Revenues			0.7	0.4	0.0	0.0	0.0	0.0
Cost of goods sold			0.0	0.0	0.0	0.0	0.0	0.0
Gross profit			0.7	0.4	0.0	0.0	0.0	0.0
Gross margin			100.0%	100.0%
Selling, general and administrative [+]			88.8	86.1	82.4	77.5	51.5	46.3
General and administrative			149.9	147.2	143.5	138.5	83.8	78.6
Other selling, general and administrative						-61.1
Research and development			134.3	120.3	103.2		87.9	69.5
Other operating expenses						-0.3
EBITDA [+]			-221.1	-205.2	-184.7	-165.0	-133.1	-110.3
EBITDA growth			66.1%	86.0%	100.5%	107.7%	86.2%	78.9%
EBITDA margin			-31715.6%	-56054.4%
Depreciation and amortization			1.0	0.6	0.6	0.0	2.5	1.6
EBIT [+]			-222.1	-205.7	-185.3	-165.0	-135.5	-111.9
EBIT growth			63.8%	83.9%	100.1%	107.7%	88.9%	80.9%
EBIT margin			-31858.5%	-56213.4%
Interest income			3.3	0.8	0.1		0.0
Interest income			3.3	0.8	0.1		0.0
Other income (expense), net				-0.4	-0.2	-0.2		-3.4
Pre-tax income			-219.2	-205.3	-185.4	-165.2	-139.1	-115.3
Income taxes			0.0	0.0	0.0	0.0	0.0	0.0
Tax rate			0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income			-219.2	-205.3	-185.4	-165.2	-139.1	-115.3
Net margin			-31444.5%	-56091.5%

Basic EPS [+]			($5.65)	($5.68)	($5.53)	($4.94)	($4.25)	($3.60)
Growth			32.8%	57.7%	81.6%	86.0%	49.6%	8.7%
Diluted EPS [+]			($5.65)	($5.68)	($5.53)	($4.94)	($4.25)	($3.60)
Growth			32.8%	57.7%	81.6%	86.0%	49.6%	8.7%

Shares outstanding (basic) [+]			38.8	36.2	33.5	33.4	32.7	32.0
Growth			18.6%	12.9%	7.1%	9.1%	30.0%	72.5%
Shares outstanding (diluted) [+]			38.8	36.2	33.5	33.4	32.7	32.0
Growth			18.6%	12.9%	7.1%	9.1%	30.0%	72.5%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.